BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11722426)

  • 1. TAFI antigen and D-dimer levels during normal pregnancy and at delivery.
    Chabloz P; Reber G; Boehlen F; Hohlfeld P; de Moerloose P
    Br J Haematol; 2001 Oct; 115(1):150-2. PubMed ID: 11722426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer concentrations during normal pregnancy, as measured by ELISA.
    Francalanci I; Comeglio P; Liotta AA; Cellai AP; Fedi S; Parretti E; Mello G; Prisco D; Abbate R
    Thromb Res; 1995 Jun; 78(5):399-405. PubMed ID: 7660356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
    Koh SC; Anandakumar C; Biswas A; Fong YF
    Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
    Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
    Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed.
    Kline JA; Williams GW; Hernandez-Nino J
    Clin Chem; 2005 May; 51(5):825-9. PubMed ID: 15764641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy.
    Kovac M; Mikovic Z; Rakicevic L; Srzentic S; Mandic V; Djordjevic V; Radojkovic D; Elezovic I
    Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):27-30. PubMed ID: 19804940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women.
    Réger B; Péterfalvi A; Litter I; Pótó L; Mózes R; Tóth O; Kovács GL; Losonczy H
    Thromb Res; 2013 Apr; 131(4):e183-7. PubMed ID: 23481480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
    Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
    Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma D-dimer levels in normal and complicated pregnancies.
    Nolan TE; Smith RP; Devoe LD
    Obstet Gynecol; 1993 Feb; 81(2):235-8. PubMed ID: 8423957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestation-specific D-dimer reference ranges: a cross-sectional study.
    Murphy N; Broadhurst DI; Khashan AS; Gilligan O; Kenny LC; O'Donoghue K
    BJOG; 2015 Feb; 122(3):395-400. PubMed ID: 24828148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of D-dimer during pregnancy.
    Nishii A; Noda Y; Nemoto R; Ushiro K; Ohno T; Mochizuki Y; Yoshihara H; Taguchi A; Uchino N; Ohkawara S
    J Obstet Gynaecol Res; 2009 Aug; 35(4):689-93. PubMed ID: 19751328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer during pregnancy: establishing trimester-specific reference intervals.
    Gutiérrez García I; Pérez Cañadas P; Martínez Uriarte J; García Izquierdo O; Angeles Jódar Pérez M; García de Guadiana Romualdo L
    Scand J Clin Lab Invest; 2018 Oct; 78(6):439-442. PubMed ID: 29975107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy.
    Mousa HA; Downey C; Alfirevic Z; Toh CH
    Thromb Haemost; 2004 Nov; 92(5):1025-31. PubMed ID: 15543330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Dimer in normal pregnancy: determination of reference values for three commercially available assays.
    Bergmann F; Pingel N; Czwalinna A; Koch M
    Clin Chem Lab Med; 2014 Nov; 52(11):e257-9. PubMed ID: 24807168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is fibrinolysis really depressed in normal pregnancy?].
    Candotti G; Rossi E; Woodhams B; Kernoff PK
    Ann Ostet Ginecol Med Perinat; 1987; 108(6):351-8. PubMed ID: 3448977
    [No Abstract]   [Full Text] [Related]  

  • 17. D-D dimers: a poor correlate of PPIH and subsequent outcomes.
    Royle G; Barry CL; Blacklock H; Lake Y
    Int J Gynaecol Obstet; 1998 Jul; 62(1):37-42. PubMed ID: 9722123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
    Bremme K; Ostlund E; Almqvist I; Heinonen K; Blombäck M
    Obstet Gynecol; 1992 Jul; 80(1):132-7. PubMed ID: 1534880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy.
    Hansen AT; Andreasen BH; Salvig JD; Hvas AM
    Scand J Clin Lab Invest; 2011 Apr; 71(2):173-6. PubMed ID: 21190511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concentration of thrombin activatable fibrinolysis inhibitor (TAFI) in cord blood and maternal blood during labor].
    Uszyński W; Zekanowska E; Szymański W; Uszyński M
    Ginekol Pol; 2003 Oct; 74(10):1329-34. PubMed ID: 14669439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.